BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6367858)

  • 1. Multiple trials of adjuvant chemohormonal therapy in the treatment of breast cancer: preliminary results--the ECOG experience.
    Carbone PP
    Breast Cancer Res Treat; 1983; 3 Suppl():S35-8. PubMed ID: 6367858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant chemotherapy of breast cancer: a promising experiment or standard practice?
    Henderson IC
    J Clin Oncol; 1985 Feb; 3(2):140-3. PubMed ID: 3881560
    [No Abstract]   [Full Text] [Related]  

  • 3. Adjuvant systemic therapy in postoperative node-positive patients with breast carcinoma: the CALGB trial and the ECOG premenopausal trial.
    Tormey C
    Recent Results Cancer Res; 1984; 96():155-65. PubMed ID: 6396769
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant therapy of breast cancer: a Southwest Oncology Group experience.
    Rivkin SE; Glucksberg H; Foulkes M
    Recent Results Cancer Res; 1984; 96():166-74. PubMed ID: 6396770
    [No Abstract]   [Full Text] [Related]  

  • 5. Adjuvant programs for postmenopausal women with node-positive breast cancer: preliminary analysis of 5-year results.
    Rossi A; Brambilla C; Valagussa P; Bonadonna G
    Recent Results Cancer Res; 1984; 96():178-83. PubMed ID: 6396772
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomised trial of chemo-endocrine therapy, endocrine therapy, and mastectomy alone in postmenopausal patients with operable breast cancer and axillary node metastasis.
    Ludwig Breast Cancer Study Group
    Lancet; 1984 Jun; 1(8389):1256-60. PubMed ID: 6144974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ludwig Breast Cancer trial LBCS III: chemo- and endocrine adjuvant treatment in postmenopausal patients.
    Gelber RD
    Recent Results Cancer Res; 1984; 96():102-9. PubMed ID: 6396763
    [No Abstract]   [Full Text] [Related]  

  • 8. Adjuvant therapy of breast cancer: the Southwest Oncology Group experience.
    Knight WA; Rivkin SE; Glucksberg H; Foulkes MA; Costanzi JJ; Stephens RL; Athens JW; O'Bryan RM
    Breast Cancer Res Treat; 1983; 3 Suppl():S27-33. PubMed ID: 6367857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of a natural history data base to compare outcome among several trials of adjuvant chemotherapy for stage II breast cancer.
    Jones SE; Moon TE
    Recent Results Cancer Res; 1984; 96():148-54. PubMed ID: 6396768
    [No Abstract]   [Full Text] [Related]  

  • 10. Adjuvant therapy in primary breast cancer.
    Wolmark N; Fisher B
    Surg Clin North Am; 1985 Feb; 65(1):161-80. PubMed ID: 3887616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant chemo-endocrine therapy or endocrine therapy alone for postmenopausal patients: Ludwig Studies III and IV.
    Goldhirsch A; Gelber RD
    Recent Results Cancer Res; 1989; 115():153-62. PubMed ID: 2696027
    [No Abstract]   [Full Text] [Related]  

  • 12. Scottish adjuvant breast cancer trials: results in pre-menopausal patients.
    Stewart HJ
    Recent Results Cancer Res; 1989; 115():126-31. PubMed ID: 2696025
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemo- or endocrine adjuvant therapy alone or combined in postmenopausal patients (GABG Trial 1).
    Jonat W; Kaufmann M; Abel U
    Recent Results Cancer Res; 1989; 115():163-9. PubMed ID: 2696028
    [No Abstract]   [Full Text] [Related]  

  • 14. Postmenopausal node-positive comparison of observation with CMFP and CMPF + tamoxifen adjuvant therapy: an Eastern Cooperative Oncology Group trial.
    Tormey DC; Taylor SG; Gray R; Olson JE
    Recent Results Cancer Res; 1984; 96():110-6. PubMed ID: 6396764
    [No Abstract]   [Full Text] [Related]  

  • 15. Tamoxifen and combination chemotherapy as adjuvant treatment in postmenopausal women with breast cancer.
    Wallgren A; Baral E; Beling U; Carstensen J; Friberg S; Glas U; Kaigas M; Skoog L
    Recent Results Cancer Res; 1984; 96():197-203. PubMed ID: 6396775
    [No Abstract]   [Full Text] [Related]  

  • 16. Adjuvant CMFP versus CMFP plus tamoxifen versus observation alone in postmenopausal, node-positive breast cancer patients: three-year results of an Eastern Cooperative Oncology Group study.
    Taylor SG; Kalish LA; Olson JE; Cummings F; Bennett JM; Falkson G; Tormey DC; Carbone PP
    J Clin Oncol; 1985 Feb; 3(2):144-54. PubMed ID: 3881561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant systemic therapy for resectable breast cancer.
    Bonadonna G; Valagussa P
    J Clin Oncol; 1985 Feb; 3(2):259-75. PubMed ID: 3881562
    [No Abstract]   [Full Text] [Related]  

  • 18. Adjuvant therapy for breast cancer: a brief overview of the NSABP experience and some thoughts on neoadjuvant chemotherapy.
    Fisher B
    Recent Results Cancer Res; 1986; 103():54-68. PubMed ID: 3526476
    [No Abstract]   [Full Text] [Related]  

  • 19. Ludwig Breast Cancer trials LBCS III and IV: adjuvant endocrine treatment in postmenopausal patients.
    Goldhirsch A
    Recent Results Cancer Res; 1984; 96():204-9. PubMed ID: 6549355
    [No Abstract]   [Full Text] [Related]  

  • 20. A controlled trial of adjuvant chemotherapy with melphalan versus cyclophosphamide, methotrexate, and fluorouracil for breast cancer.
    Howell A; Rubens RD; Bush H; George WD; Howat JM; Crowther D; Sellwood RA; Hayward JL; Knight RK; Bulbrook RD
    Recent Results Cancer Res; 1984; 96():74-89. PubMed ID: 6396780
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.